Cargando…
141. Evaluating Cefepime And Alternative Beta-lactams For The Treatment Of Serratia marcescens Blood Stream Infections
BACKGROUND: AmpC β-lactamase enzymes can be produced by a number of Enterobacterales. Due to its inducible chromosomal resistance, cefepime is often preferred. In vitro analysis and clinical reports have shown AmpC expression can occur less than 5% among S. marcescens. Locally, there has been a rise...
Autores principales: | Vicente-Lopez, Natcha, Patel, Radha, Stock, Kent J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751995/ http://dx.doi.org/10.1093/ofid/ofac492.219 |
Ejemplares similares
-
193. Standard of Care versus Alternative Beta-lactams for Treatment of Infections due to Serratia marcescens
por: Green, Sarah B, et al.
Publicado: (2023) -
2789. Cefepime Versus Non-Cefepime/Non-Carbapenem Therapy for Blood Stream Infections Caused by Non-ESBL-Producing Serratia Marcescens: A Subgroup Analysis of The Carbapenem-Serratia Multicenter Retrospective Cohort Study
por: Mughrabi, Abdallah, et al.
Publicado: (2023) -
2788. Cefepime or Carbapenem Definitive Therapy Versus Other Antibiotics for Blood Stream Infections Caused by Non-ESBL-Producing Serratia Marcescens: A Multicenter Retrospective Cohort Study
por: Mughrabi, Abdallah, et al.
Publicado: (2023) -
Etymologia: Serratia marcescens
por: Nazzaro, Gianluca
Publicado: (2019) -
Serratia marcescens Endocarditis
por: Elkattawy, Sherif, et al.
Publicado: (2021)